PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 133 filers reported holding PDL BIOPHARMA INC in Q3 2020. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $3,613,000 | +106.3% | 1,269,799 | +135.4% | 1.36% | +220.6% |
| Q2 2020 | $1,751,000 | -0.6% | 539,450 | -13.7% | 0.42% | -39.7% |
| Q1 2020 | $1,762,000 | +0.6% | 624,783 | +15.8% | 0.70% | +65.7% |
| Q4 2019 | $1,751,000 | +50.3% | 539,450 | 0.0% | 0.42% | +46.4% |
| Q3 2019 | $1,165,000 | -31.2% | 539,450 | 0.0% | 0.29% | -32.2% |
| Q2 2019 | $1,694,000 | -24.2% | 539,450 | -10.2% | 0.43% | -23.8% |
| Q1 2019 | $2,235,000 | +13.2% | 600,750 | -11.8% | 0.56% | +9.4% |
| Q4 2018 | $1,975,000 | +19.6% | 680,950 | +8.5% | 0.51% | +30.7% |
| Q3 2018 | $1,651,000 | +108.7% | 627,800 | +85.7% | 0.39% | +100.5% |
| Q2 2018 | $791,000 | – | 338,141 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Argent Trust Co | 41,405 | $102,270 | 0.01% |
| Diversified Trust Co | 11,029 | $26,469 | 0.00% |
| HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
| RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
| Ancora Advisors LLC | 4,948 | $0 | 0.00% |
| Westside Investment Management, Inc. | 500 | $0 | 0.00% |